Patent application number | Description | Published |
20110296179 | Encryption System using Web Browsers and Untrusted Web Servers - In one embodiment of the present invention, a first user—the creator—uses a web browser to encrypt some information. The web browser provides to the creator a URL which contains the key used for encryption, such as in the form of an anchor embedded within a URL. The web browser also provides a hash of the cryptographic key and the encrypted information to a web server. The creator transmits the URL to a second user—the viewer—who provides the URL to a web browser, thereby causing the web browser to navigate to a decryption web page maintained by the web server, but without transmitting the cryptographic key to the web server. The viewer's web browser hashes the cryptographic key and sends the hash to the web server, which uses the hash to identify and return the encrypted information to the viewer's web browser, which in turn uses the encryption key to decrypt the message and display the decrypted message to the viewer. | 12-01-2011 |
20150207783 | ENCRYPTION SYSTEM USING WEB BROWSERS AND UNTRUSTED WEB SERVERS - In one embodiment of the present invention, a first user—the creator—uses a web browser to encrypt some information. The web browser provides to the creator a URL which contains the key used for encryption, such as in the form of an anchor embedded within a URL. The web browser also provides a hash of the cryptographic key and the encrypted information to a web server. The creator transmits the URL to a second user—the viewer—who provides the URL to a web browser, thereby causing the web browser to navigate to a decryption web page maintained by the web server, but without transmitting the cryptographic key to the web server. The viewer's web browser hashes the cryptographic key and sends the hash to the web server, which uses the hash to identify and return the encrypted information to the viewer's web browser, which in turn uses the encryption key to decrypt the message and display the decrypted message to the viewer. | 07-23-2015 |
Patent application number | Description | Published |
20090049587 | Toilet Device With Cleanser and Fragrance - Described is a multi-function device for attachment to the tank of a toilet fixture. The multi-function device provides a diffusible air-treatment concentrate for deodorizing or otherwise treating the ambient air surrounding the toilet. At the same time, the multi-function device provides a water-soluble water-treatment concentrate for treating the flush water stored in the toilet tank. The multi-function device has a bellows with a varying cross-sectional area to provide, during a flush cycle, a variable flow of air over the air treatment concentrate and into the air. | 02-26-2009 |
20090064401 | Toilet Device With Improved Fragrance Delivery - Described is a single function or multi-function device for attachment to the tank of a toilet fixture. The device provides a diffusible air-treatment concentrate for deodorizing or otherwise treating the ambient air surrounding the toilet. At the same time, the multi-function device provides a water-soluble water-treatment concentrate for treating the flush water stored in the toilet tank. The device can have an air moving part with a delay value to increase fragrance delivery. The device can have an air treatment part with a reservoir having fragrance containing particles. The reservoir can have an attachment means so that it can be replaced when the fragrance is used up. The device can deliver a burst of fragranced air during a toilet flush cycle. | 03-12-2009 |
20100187263 | Foamable Composition Containing Alcohol - This invention relates to compositions containing lower (C1-C4) alcohol and a polymeric fluorosurfactant formulated for being dispensed as a foam product. More particularly, the invention relates to improved compositions formulated with polymeric fluorosurfactants with pendant perfluoroalkyl side chains of a fully fluorinated chain length of C1-C7. The compositions also relate to use for personal care, such as skin sanitizing and cleansing. | 07-29-2010 |
20100189611 | Foamable Composition Containing Alcohol - This invention relates to compositions containing lower (C1-C4) alcohol and a polymeric fluorosurfactant formulated for being dispensed as a foam product. More particularly, the invention relates to improved compositions formulated with polymeric fluorosurfactants with pendant perfluoroalkyl side chains of a fully fluorinated chain length of C1-C7. The compositions also relate to use for personal care, such as skin sanitizing and cleansing. | 07-29-2010 |
20100189809 | Foamable Compositions Containing Alcohol - This invention relates to compositions containing lower (C1-C4) alcohol and a polymeric fluorosurfactant formulated for being dispensed as a foam product. More particularly, the invention relates to improved compositions formulated with polymeric fluorosurfactants with pendant perfluoroalkyl side chains of a fully fluorinated chain length of C1-C7. The compositions also relate to use for personal care, such as skin sanitizing and cleansing. | 07-29-2010 |
20130019388 | TOILET DEVICE WITH INDICATOR - Described is a multi-function device for attachment to the tank of a toilet fixture. The multi-function device provides a diffusible air-treatment concentrate for deodorizing or otherwise treating the ambient air surrounding the toilet. At the same time, the multi-function device provides a water-soluble water-treatment concentrate for treating the flush water stored in the toilet tank. The multi-function device has an indicator to advise the consumer when replacement of user serviceable parts, such as the water treatment concentrate and the air treatment concentrate, is needed. The multi-function device has a bellows with a varying cross-sectional area to provide, during a flush cycle, a variable flow of air over the air treatment concentrate and into the air. | 01-24-2013 |
Patent application number | Description | Published |
20110296179 | Encryption System using Web Browsers and Untrusted Web Servers - In one embodiment of the present invention, a first user—the creator—uses a web browser to encrypt some information. The web browser provides to the creator a URL which contains the key used for encryption, such as in the form of an anchor embedded within a URL. The web browser also provides a hash of the cryptographic key and the encrypted information to a web server. The creator transmits the URL to a second user—the viewer—who provides the URL to a web browser, thereby causing the web browser to navigate to a decryption web page maintained by the web server, but without transmitting the cryptographic key to the web server. The viewer's web browser hashes the cryptographic key and sends the hash to the web server, which uses the hash to identify and return the encrypted information to the viewer's web browser, which in turn uses the encryption key to decrypt the message and display the decrypted message to the viewer. | 12-01-2011 |
20150207783 | ENCRYPTION SYSTEM USING WEB BROWSERS AND UNTRUSTED WEB SERVERS - In one embodiment of the present invention, a first user—the creator—uses a web browser to encrypt some information. The web browser provides to the creator a URL which contains the key used for encryption, such as in the form of an anchor embedded within a URL. The web browser also provides a hash of the cryptographic key and the encrypted information to a web server. The creator transmits the URL to a second user—the viewer—who provides the URL to a web browser, thereby causing the web browser to navigate to a decryption web page maintained by the web server, but without transmitting the cryptographic key to the web server. The viewer's web browser hashes the cryptographic key and sends the hash to the web server, which uses the hash to identify and return the encrypted information to the viewer's web browser, which in turn uses the encryption key to decrypt the message and display the decrypted message to the viewer. | 07-23-2015 |
Patent application number | Description | Published |
20080318837 | Pharmaceutical Formation For Increased Epithelial Permeability of Glucose-Regulating Peptide - What is described is a pharmaceutical formulation comprising a mixture of a pharmaceutically effective amount of glucose-regulating peptide (GRP) and enhancers, wherein the pharmaceutical formulation is used in the treatment of a metabolic syndrome. | 12-25-2008 |
20090042823 | USES OF BROAD SPECTRUM RNAI THERAPEUTICS AGAINST INFLUENZA - Methods and uses of RNAi-inducing agents for medicaments and treating or preventing a viral infection. | 02-12-2009 |
20090220435 | TIGHT JUNCTION MODULATING PEPTIDE COMPONENTS FOR ENHANCING MUCOSAL DELIVERY OF THERAPEUTIC AGENTS - Compounds and components including sequences for mucosal epithelial transport of an active agent are given. Tight junction modulating peptide components are described for use in transport and delivery. Permeability can be enhanced with reversibility. Compounds and components for enhanced delivery may be peptide or protein variants, conjugates, or other analog types and structures. | 09-03-2009 |
20100112042 | Processes and Compositions for Liposomal and Efficient Delivery of Gene Silencing Therapeutics - Processes and compositions for liposomal delivery of therapeuticals prepared by contacting an aqueous solution of an active agent with a solution of liposome-forming components containing one or more DILA2 amino acid compounds or lipids in organic solvent to form an impinging stream. A protocol including flow rates, pH, and an incubation period are used to control formation of liposomal components for therapeutic applications. The impinging stream may be collected and incubated to prepare a liposomal formulation which encapsulates the active agent. The composition can be quenched with buffer and filtered by tangential flow and diafiltration and other means for finishing as a pharmaceutical composition. An efficiency for delivering a drug cargo is provided. Compositions can include a liposome containing one or more carrier particles, each carrier particle having an active agent and a peptide, wherein the ratio of the mass of the peptide plus the mass of the liposome to the mass of the active agent is less than about 15. | 05-06-2010 |
20110313020 | UsiRNA Complexes - This disclosure provides double-stranded RNA complexes having one or more hydroxymethyl substituted nucleomonomer(s) in the passenger strand (or sense strand) of an RNA complex. RNA complexes of the disclosure may be useful for therapeutic applications, diagnostic applications or research applications. RNA complexes include short interfering RNA complexes (siRNA) capable of modulating gene expression comprising an antisense strand and a continuous or a discontinuous passenger strand (“sense strand”). Further, one or more hydroxymethyl substituted nucleomonomer(s) of this disclosure may be positioned at the 3′-end, at the 5′-end, at both the 3′-end and 5′end. | 12-22-2011 |
20120277289 | ACTIVITY GENERATING DELIVERY MOLECULES - Activity-generating delivery molecules comprising the structure R | 11-01-2012 |
20130039970 | Processes and Compositions for Liposomal and Efficient Delivery of Gene Silencing Therapeutics - Processes and compositions for liposomal delivery of therapeuticals prepared by contacting an aqueous solution of an active agent with a solution of liposome-forming components containing one or more DILA2 amino acid compounds or lipids in organic solvent to form an impinging stream. A protocol including flow rates, pH, and an incubation period are used to control formation of liposomal components for therapeutic applications. The impinging stream may be collected and incubated to prepare a liposomal formulation which encapsulates the active agent. The composition can be quenched with buffer and filtered by tangential flow and diafiltration and other means for finishing as a pharmaceutical composition. | 02-14-2013 |
20130190383 | NUCLEIC ACID COMPOUNDS WITH CONFORMATIONALLY RESTRICTED MONOMERS AND USES THEREOF - This disclosure provides single-stranded and multi-stranded nucleic acid compounds having one or more double-stranded regions that regulate the function or expression of nucleic acid molecules expressed in a cell or a cell regulatory system dependent upon a nucleic acid. The disclosure provides a range of nucleic acid compounds having one or more conformationally restricted nucleomonomers (CRN). Certain nucleic acid compounds may have one or more conformationally restricted nucleomonomers and one or more hydroxymethyl substituted nucleomonomers (UNA). The nucleic acid compounds are useful in various therapeutic modalities. | 07-25-2013 |
20150073038 | DELIVERY MOLECULES FOR THERAPEUTICS - Activity-generating delivery molecules comprising the structure R | 03-12-2015 |
20150209283 | PROCESSES AND COMPOSITIONS FOR LIPOSOMAL AND EFFICIENT DELIVERY OF GENE SILENCING THERAPEUTICS - Processes and compositions for liposomal delivery of therapeuticals prepared by contacting an aqueous solution of an active agent with a solution of liposome-forming components containing one or more DILA2 amino acid compounds or lipids in organic solvent to form an impinging stream. A protocol including flow rates, pH, and an incubation period are used to control formation of liposomal components for therapeutic applications. The impinging stream may be collected and incubated to prepare a liposomal formulation which encapsulates the active agent. The composition can be quenched with buffer and filtered by tangential flow and diafiltration and other means for finishing as a pharmaceutical composition. | 07-30-2015 |
20150284717 | OLIGOMERS WITH CONFORMATIONALLY RESTRICTED MONOMERS AND UNLOCKED NUCLEOMONOMERS - This invention provides single-stranded and multi-stranded compounds that are useful in various therapeutic modalities to regulate the expression of nucleic acid molecules in a cell. A range of compounds is provided, each containing one or more conformationally restricted nucleomonomers (CRN). In addition, compounds can contain one or more conformationally restricted nucleomonomers and one or more hydroxymethyl substituted nucleomonomers (unlocked nucleomonomers, UNA). | 10-08-2015 |